Monday , December 9 2019
Home / italy / "Possible latex in containers, risks for allergy sufferers"

"Possible latex in containers, risks for allergy sufferers"



Flu, alert for 7 vaccines. AIFA:

Flu Shots, Possible Latex Traces in the pre-filled syringe components or nasal applicators of 7 influenza vaccines produced by three pharmaceutical companies for the 2019-2020 season. An eventuality not excluded by the Italian Drug Agency (Aifa) and which can be dangerous for latex allergy sufferers who, in the presence of this substance, even in traces, would be exposed to the risk of allergic reactions. The Agency's invitation to allergy sufferers is therefore to consult the doctor before the vaccine is given.

<! –

->

Flu 2019 in bed 341,000 Italians: the virus is almost epidemic

'The warning issued by Aifa refers only to the packaging of influenza vaccines to protect those with allergies to influenza. This allows even allergy sufferers to vaccinate properly by informing them of latex-free products. Therefore, there is no contamination in influenza vaccines », specified the agency. Possible traces of latex they do not concern the vaccines themselves, but external components such as, in fact, syringe elements such as the cylinder, piston, needle cap and tip caps, or may have been determined by contact during the injection process. production.

Rome, 11-year-old girl at risk of infection: class and teachers vaccinated against measles

Cold and Bronchial Problems: An Online Guide to Defending Yourself

Nothing to do with cases like Novartis Fluad vaccine, of which in 2014 some batches were withdrawn following notification of several suspected deaths following product administration. In the case of trellis risk, AIFA has carried out an in-depth study with vaccine authorization companies (AICs) for the protection of allergy sufferers. Based on EU guidelines, a warning is already included in the Product Information Sheet if latex is present in any quantity. In the absence of latex, however, the inclusion of specific statements is not required.

Bimbo has leukemia, his teammates are vaccinated to allow him to return to school

To better protect allergic persons, however, AIFA has requested, when not specified in the leaflet, to certify the presence or absence of latex in the primary packaging components by contacting all companies involved. The verification showed that for 7 vaccines, the presence of latex is not excluded. This is the company Mylan IRE HEALTHCARE LIMITED with the vaccine "Influvac S tetrà" for which the AIFA specifies that 'it contains no latex' but 'the possibility that during the production process the vaccine may have come into contact with tools containing latex' cannot be excluded; Mylan Italia Srl with the vaccine & # 39; Influvac S * & # 39;; the Seqirus srl company with the Agrippal S1, Fluad, Influpozzi subunit, Innoflu *, Flucelvax tetra vaccines. For these latter vaccines "it cannot be excluded that needle caps and caps need not be latex-resistant. "Therefore, AIFA advises latex-sensitive patients to consult their physician before administering the vaccine. The goal, Aifa notes, is therefore to provide" brief information to further contribute to safe use. and correct for seasonal influenza vaccines, even those with a history of severe latex allergic reactions. "

THIS IS THE DETAIL OF VACCINES
– Influvac S tetra * (Mylan Ire Healthcare Limited) 'Contains no latex – the possibility cannot be ruled out that during the production process the vaccine may come into contact with instruments containing latex. Latex sensitive patients are advised to consult a physician before administering the vaccine.

– Influvac S * (Mylan Italia S.r.l.) 'Contains no latex – the possibility cannot be excluded that during the production process the vaccine will come into contact with instruments containing latex. Latex sensitive patients are advised to consult a physician before administering the vaccine.

Fluarix tetra * (Glaxo Smith Kline Biologicals Sa) "contains no latex – not used in the production process".

Vaxigrip tetra * (Sanofi Pasteur Europe) "does not contain latex – not used in the production process".

For Agrippal S1 *, Fluad *, Influpozzi * subunit, Innoflu * and Flucelvax tetra * (Seqirus srl) 'It cannot be excluded that needle caps and syringe caps do not contain latex. Latex sensitive patients are advised to consult a physician before administering the vaccine. Finally, Fluenz tetra * (AstraZeneca AB) 'contains no latex – is not used in the production process'.

Last updated at 21:16


© RESERVED PLAYBACK


Source link